<bill session="115" type="h" number="5806" updated="2019-04-18T16:23:32Z">
  <state datetime="2018-05-17">REPORTED</state>
  <status>
    <unknown datetime="2018-05-17"/>
  </status>
  <introduced datetime="2018-05-15"/>
  <titles>
    <title type="official" as="introduced">To require the Secretary of Health and Human Services to issue guidance with respect to the expedited approval of certain drugs, and for other purposes.</title>
    <title type="short" as="introduced">21st Century Tools for Pain and Addiction Treatment Act</title>
    <title type="short" as="introduced">21st Century Tools for Pain and Addiction Treatment Act</title>
    <title type="display">21st Century Tools for Pain and Addiction Treatment Act</title>
  </titles>
  <sponsor bioguide_id="B001248"/>
  <cosponsors>
    <cosponsor bioguide_id="B001243" joined="2018-05-18"/>
    <cosponsor bioguide_id="B001275" joined="2018-05-15"/>
    <cosponsor bioguide_id="G000568" joined="2018-05-15"/>
    <cosponsor bioguide_id="W000791" joined="2018-05-25"/>
  </cosponsors>
  <actions>
    <action datetime="2018-05-15">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-05-15" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2018-05-17">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <calendar datetime="2018-05-17" state="REPORTED">
      <text>Ordered to be Reported by the Yeas and Nays: 31 - 23.</text>
    </calendar>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="115" relation="unknown" number="6"/>
    <bill type="s" session="115" relation="unknown" number="2680"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Public participation and lobbying"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
